TeamDrive
RUS

Russian-made medicines account for up to 72% of public procurement in Russia

12 March 2018

GMP News

In 2017, the public procurement of medicines decreased slightly (with stronger decline in physical rather than monetary terms) and amounted to 340 billion rubles and 0.88 billion packages. These figures were reported in the review of public procurement of medicines for 2017.

Prescription drugs accounted for about 98% of procurement in monetary terms and 90% in physical terms. Russian-made medicines accounted to 72% of procurement in terms of packages or 45% in monetary terms. More than 80% of medicinal products in the public segment (both in monetary and physical terms) are included in the List of Vital and Essential Drugs.

SG Biotech was the most prominent among the manufacturers of drugs shipped to state health facilities following the public procurement. This joint venture between Generium, a Russian biotech company, and Shire, an Irish pharmaceutical company, was registered in Russia in 2016 to supply drugs for hemophilia included in the list of high-cost nosologies. 2017 was a successful year for SG Biotech, as it jumped from 16th to the 9th position in the ranking. Among Top 20 companies, the most significant decline was reported for Celgene, which dropped by 8 positions in the ranking. This is associated with the price reduction for lenalidomide, its flagship INN, caused by the emergence of competitors in the auctions.


Previous publication Next publication

Media Center

  • 20 June 2018

    First Russian intradermal implant obtained registration

    The first Russian intradermal implant has successfully passed the state registration. This product has been developed over the past three years with the support of the Russian Ministry of Industry and Trade as part of the state policy of import substitution.

  • 20 June 2018

    EEC changed rules for registration of vaccines and use of GMP certificates

    The Council of the Eurasian Economic Commission (EEC) has amended the rules for registration and expert examination of medicinal products for human use in the Eurasian Economic Union. In particular, it adopted common approaches to the procedure for changing the registration documents for flu prevention vaccines.

  • 19 June 2018

    Russia is ready to supply insulin to Bulgaria

    The time has come to reduce imports from abroad and start establishing contacts with neighbors,” said Ivan Zarubin, acting Trade Representative of the Russian Federation in the Republic of Bulgaria, speaking at the Medicine and Pharmacy 2018, a Bulgarian-Russian business forum held in Sofia on June 13.

  • 19 June 2018

    Construction of a new pharmaceutical plant started in Usolye-Sibirskoye

    An official ceremony marking the launch of construction was held at the site of future plant for active pharmaceutical substances and finished medicinal products of Pharmasyntez-Chemie in Usolye-Sibirskoye on June 15.

Read more